BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3075858)

  • 1. Analysis of lymphocyte phenotype in human thymomas.
    Berrih-Aknin S; Safar D; Cohen-Kaminsky S
    Adv Exp Med Biol; 1988; 237():369-74. PubMed ID: 3075858
    [No Abstract]   [Full Text] [Related]  

  • 2. Demonstration of phenotypic abnormalities of thymic epithelium in thymoma including two cases with abundant Langerhans cells.
    Kraus VB; Harden EA; Wittels B; Moore JO; Haynes BF
    Am J Pathol; 1988 Sep; 132(3):552-62. PubMed ID: 3261946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunohistologic study of the epithelial components of 81 cases of thymoma.
    Fukai I; Masaoka A; Hashimoto T; Yamakawa Y; Mizuno T; Tanamura O; Hirokawa K; Ueda R
    Cancer; 1992 May; 69(10):2463-8. PubMed ID: 1373667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased frequency of intrathymic regulatory T cells in patients with myasthenia-associated thymoma.
    Luther C; Poeschel S; Varga M; Melms A; Tolosa E
    J Neuroimmunol; 2005 Jul; 164(1-2):124-8. PubMed ID: 15923045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on lymphocyte subsets in thymic tissue and functions of peripheral lymphocytes in patients with tumorous thymus with special reference to myasthenia gravis.
    Tanino M; Koide O; Shimazu A; Suzuki K; Yoshimatsu H
    Acta Pathol Jpn; 1988 Apr; 38(4):425-34. PubMed ID: 3261110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of CD20 in thymomas and its clinical implication].
    Du J; Zhou XJ; Yin HL; Lu ZF; Zhou HB
    Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):611-4. PubMed ID: 21092589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An immunohistologic study of the epithelial and lymphoid components of six thymomas.
    van der Kwast TH; van Vliet E; Cristen E; van Ewijk W; van der Heul RO
    Hum Pathol; 1985 Oct; 16(10):1001-8. PubMed ID: 2412943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen presentation by thymoma epithelial cells from myasthenia gravis patients to potentially pathogenic T cells.
    Gilhus NE; Willcox N; Harcourt G; Nagvekar N; Beeson D; Vincent A; Newsom-Davis J
    J Neuroimmunol; 1995 Jan; 56(1):65-76. PubMed ID: 7822483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [B-cells in thymic epithelial tumors: phenotype, distribution and relation to the intramedullary B-cell population of the normal thymus].
    Fend F; Kirchner T; Marx A; Müller-Hermelink HK
    Verh Dtsch Ges Pathol; 1992; 76():253-5. PubMed ID: 1283270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Abnormal T cell maturation in myasthenia gravis associated thymomas].
    Nenninger R; Schultz A; Müller-Hermelink HK; Marx A
    Verh Dtsch Ges Pathol; 1996; 80():256-60. PubMed ID: 9065022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metaplastic thymoma with myasthenia gravis presumably caused by an accumulation of intratumoral immature T cells: a case report.
    Tajima S; Yanagiya M; Sato M; Nakajima J; Fukayama M
    Int J Clin Exp Pathol; 2015; 8(11):15375-80. PubMed ID: 26823897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistology of human thymomas.
    Kornstein MJ; Hoxie JA; Levinson AI; Brooks JJ
    Arch Pathol Lab Med; 1985 May; 109(5):460-3. PubMed ID: 2580505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myasthenic and nonmyasthenic thymoma. An expansion of a minor cortical epithelial cell subset?
    Willcox N; Schluep M; Ritter MA; Schuurman HJ; Newsom-Davis J; Christensson B
    Am J Pathol; 1987 Jun; 127(3):447-60. PubMed ID: 2438939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymoma: an immunohistochemical study.
    Chan WC; Zaatari GS; Tabei S; Bibb M; Brynes RK
    Am J Clin Pathol; 1984 Aug; 82(2):160-6. PubMed ID: 6380266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymic epithelial antigen, acquired during ontogeny and defined by the anti-p19 monoclonal antibody, is lost in thymomas.
    Savino W; Berrih S; Dardenne M
    Lab Invest; 1984 Sep; 51(3):292-6. PubMed ID: 6433106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type B thymomas in patients with myasthenia gravis display a distinctive pattern of αβ TCR and IL-7 receptor α expression on CD4
    Wang T; Wang B; Fan X; Cai Y; Li L; Fu S
    Autoimmunity; 2024 Apr; 57(1):2347379. PubMed ID: 38723105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the malignant grade of thymoma by morphometric analysis.
    Nomori H; Horinouchi H; Kaseda S; Ishihara T; Torikata C
    Cancer; 1988 Mar; 61(5):982-8. PubMed ID: 3338061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathological basis of thymoma-associated myasthenia gravis.
    Müller-Hermelink HK; Marx A; Geuder K; Kirchner T
    Ann N Y Acad Sci; 1993 Jun; 681():56-65. PubMed ID: 7689313
    [No Abstract]   [Full Text] [Related]  

  • 19. Study on the ratio of lymphocytes to epithelial cells in thymoma.
    Masaoka A; Nagaoka Y; Maeda M; Monden Y; Seike Y
    Cancer; 1977 Sep; 40(3):1222-8. PubMed ID: 902240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological study of thymomas--correlation of histologic subtype to myasthenia gravis and prognosis.
    Sundaram C; Rajagopal P; Rakshak AD; Omprakash G; Das SM; Murthy JM
    Indian J Pathol Microbiol; 2003 Jul; 46(3):378-81. PubMed ID: 15025278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.